These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38035081)

  • 21. Value of
    Miao Y; Feng R; Yu T; Guo R; Zhang M; Wang Y; Hai W; Shangguan C; Zhu Z; Li B
    J Nucl Med; 2024 Feb; 65(2):213-220. PubMed ID: 38164574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between
    Zhao L; Liu J; Wang H; Shi J
    Br J Radiol; 2021 Mar; 94(1119):20200397. PubMed ID: 33492995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of [
    Qiao K; Qin X; Fu S; Ren J; Jia J; Hu X; Tao Y; Yuan S; Wei Y
    Eur Radiol; 2024 Mar; 34(3):1948-1959. PubMed ID: 37670186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
    Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation between PD-L1 expression and metabolic parameters of
    Xu X; Li J; Yang Y; Sang S; Deng S
    Clin Imaging; 2022 Sep; 89():120-127. PubMed ID: 35797878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of positron emission tomography/computed tomography-based parameters in locally advanced esophageal squamous cell carcinoma treated with chemoradiation therapy.
    Zhang W; Jia H; Cheng Z; Diao W; Wang Y; Cao B; Kou Y; Wang Q
    Nucl Med Commun; 2022 Dec; 43(12):1239-1246. PubMed ID: 36345769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma.
    Hu B; Xiao J; Xiu Y; Fu Z; Shi H; Cheng D
    Nucl Med Commun; 2020 Mar; 41(3):252-259. PubMed ID: 32068670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer.
    Miyazawa T; Otsubo K; Sakai H; Kimura H; Chosokabe M; Morikawa K; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
    Cancer Control; 2021; 28():10732748211038314. PubMed ID: 34384268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between PD-L1 Expression and Metabolic Activity on
    Takada K; Toyokawa G; Tagawa T; Kohashi K; Akamine T; Takamori S; Hirai F; Shoji F; Okamoto T; Oda Y; Maehara Y
    Anticancer Res; 2017 Dec; 37(12):7073-7082. PubMed ID: 29187498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of [
    Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
    Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of 2-deoxy-2-fluorine-18-fluoro-D-glucose positron emission tomography/computed tomography parameters for MYCN amplification in high-risk neuroblastoma.
    Li S; Liu J; Wang G; Feng L; Yang X; Kan Y; Wang W; Yang J
    Eur J Radiol; 2024 Jan; 170():111243. PubMed ID: 38043380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
    Seol HY; Kim YS; Kim SJ
    Thorac Cancer; 2020 Nov; 11(11):3260-3268. PubMed ID: 32951338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between PD-L1 expression and
    Choi YJ; Jo K; Hwang SH; Jeong Y; Lee JY; Kim S; Kim SW; Kim YT; Kang WJ
    Ann Nucl Med; 2021 Apr; 35(4):415-420. PubMed ID: 33656683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head-to-head Intra-individual Comparison of [
    Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
    Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head-to-Head Comparison of
    Promteangtrong C; Siripongsatian D; Jantarato A; Kunawudhi A; Kiatkittikul P; Yaset S; Boonkawin N; Chotipanich C
    J Nucl Med; 2022 Aug; 63(8):1155-1161. PubMed ID: 34857655
    [No Abstract]   [Full Text] [Related]  

  • 36. Retrospective Analysis of the Predictive Value of
    Ji J; Pang W; Song J; Wang X; Tang H; Liu Y; Yi H; Wang Y; Gu Q; Li L
    Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980323
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Chen L; Zheng S; Chen L; Xu S; Wu K; Kong L; Xue J; Chen X; Miao W; Zhu Y
    J Nucl Med; 2023 Dec; 64(12):1899-1905. PubMed ID: 37918866
    [No Abstract]   [Full Text] [Related]  

  • 38. New insight on the correlation of metabolic status on
    Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between PD-L1 expression and
    Chen R; Chen Y; Huang G; Liu J
    Aging (Albany NY); 2019 Dec; 11(24):12270-12277. PubMed ID: 31848322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor immunity is related to
    Imai H; Kaira K; Hashimoto K; Nitanda H; Taguchi R; Yanagihara A; Umesaki T; Yamaguchi O; Mouri A; Kawasaki T; Yasuda M; Kobayashi K; Sakaguchi H; Kuji I; Kagamu H
    Cancer Med; 2021 Sep; 10(18):6317-6326. PubMed ID: 34363337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.